Strategies to Alleviate the Clinical and Economic Burden of LEMS

Author(s):

Key Takeaways

Early diagnosis and personalized treatment plans are crucial in reducing the economic impact of LEMS on patients and healthcare systems.
Optimizing pharmacotherapy and utilizing telemedicine can decrease hospitalizations and facilitate ongoing patient management.
A multidisciplinary approach involving various healthcare professionals enhances patient outcomes and reduces healthcare costs.
Streamlined care coordination and improved quality of life are achieved through collaborative models, addressing both clinical and financial burdens.

A medical expert discusses strategies that have successfully mitigated the economic impact of LEMS on patients and health care systems, and how a multidisciplinary approach can reduce the clinical and economic burden of LEMS on health care delivery.

EP: 1.LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection

Now Viewing

EP: 2.Strategies to Alleviate the Clinical and Economic Burden of LEMS

EP: 3.The Clinical and Economic Impact of LEMS in SCLC Care

EP: 4.Using Technology for Early Detection of LEMS

EP: 5.Team- and System-Based Approaches to Managing LEMS and Ensuring Access

EP: 6.The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care

EP: 7.Managed Care Partnerships and Continuity of Care

Video content above is prompted by the following:

What strategies have been successful in mitigating the economic impact of Lambert-Eaton myasthenic syndrome (LEMS) on patients and health care systems?
How can a multidisciplinary approach reduce the clinical and economic burden of LEMS on health care delivery?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!